Results 11 to 20 of about 5,439,323 (304)
Dendritic cell regulation of immunity to Leishmania donovani [PDF]
, 2010 Dendritic cells lie at the interface of innate and adaptive immunity, critically contributing to the generation of an antigen-specific immune response.
Owens, Benjamin M.J.
core +6 more sources
CD300f epitopes are specific targets for acute myeloid leukemia with monocytic differentiation
Molecular Oncology, 2019 Antibody‐based therapy in acute myeloid leukemia (AML) has been marred by significant hematologic toxicity due to targeting of both hematopoietic stem and progenitor cells (HSPCs).
Edward Abadir +14 more
doaj +1 more source
CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential
Frontiers in Immunology, 2019 CD83 is a member of the immunoglobulin (Ig) superfamily and is expressed in membrane bound or soluble forms. Membrane CD83 (mCD83) can be detected on a variety of activated immune cells, although it is most highly and stably expressed by mature dendritic
Ziduo Li +13 more
doaj +1 more source
Moving on From Sipuleucel-T: New Dendritic Cell Vaccine Strategies for Prostate Cancer
Frontiers in Immunology, 2021 Tumors evade the immune system though a myriad of mechanisms. Using checkpoint inhibitors to help reprime T cells to recognize tumor has had great success in malignancies including melanoma, lung, and renal cell carcinoma.
Sarah I. M. Sutherland +10 more
doaj +1 more source
CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma
Haematologica, 2018 Chemotherapy and hematopoietic stem cell transplantation are effective treatments for most Hodgkin lymphoma patients, however there remains a need for better tumor-specific target therapy in Hodgkin lymphoma patients with refractory or relapsed disease ...
Ziduo Li +21 more
doaj +1 more source
Frontiers in Oncology, 2019 Monoclonal antibodies targeting co-inhibitory immune checkpoint molecules have been successful in clinical trials of both solid and hematological malignancies as acknowledged by the 2018 Nobel Prize in Medicine, however improving clinical response rates ...
Benjamin Y. Kong +12 more
doaj +1 more source
The disabled dendritic cell [PDF]
The FASEB Journal, 2001 ABSTRACT Dendritic cells are important antigen‐presenting cells of the immune system that induce and modulate immune responses. They interact with T and B lymphocytes as well as with natural killer cells to promote activation and differentiation of these cells.
M, Thurnher +4 more
openaire +2 more sources
Therapeutic dendritic cell vaccination against human papillomavirus [PDF]
, 2009 Cervical cancer, which is caused by infection with human papillomavirus (HPV), is the second most common cancer among women worldwide, leading to 230000 deaths annually.
Nurkkala Karlsson, Merja
core +1 more source
Dendritic Cells-Nature and Classification
Allergology International, 2007 Dendritic cells (DCs) are antigen (Ag)-presenting cells (APCs) characterized by a unique capacity to stimulate naïve T cells and initiate primary immune responses.
Katsuaki Sato, Shigeharu Fujita
doaj +1 more source
IOX1 impedes host inflammation in imiquimod-triggered psoriasis
Heliyon, 2021 Psoriasis is a chronic autoimmune disease with an unknown etiology and highly limited treatment strategies. The drugs currently used in the treatment of psoriasis are rarely recommended for long-term use owing to the serious side effects.
Joo Eun Shin +4 more
doaj +1 more source